Risultati della ricerca - Arlene A. Forastiere

Raffina i risultati
  1. 1
    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?

    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom? di Harry Quon, Arlene A. Forastiere

    Pubblicazione 2013
    Testo Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  2. 2
    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck di Athanassios Argiris, Yi Li, Arlene A. Forastiere

    Pubblicazione 2004
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes di Arlene A. Forastiere, Randal S. Weber, Andy Trotti

    Pubblicazione 2015
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    HPV-associated head and neck cancer: a virus-related cancer epidemic

    HPV-associated head and neck cancer: a virus-related cancer epidemic di Shanthi Marur, Gypsyamber D’Souza, William H. Westra, Arlene A. Forastiere

    Pubblicazione 2010
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Head and Neck Cancer: Recent Advances and New Standards of Care

    Head and Neck Cancer: Recent Advances and New Standards of Care di Arlene A. Forastiere, Andy Trotti, David G. Pfister, Jennifer R. Grandis

    Pubblicazione 2006
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy

    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy di Athanassios Argiris, Yi Li, Barbara A. Murphy, Corey J. Langer, Arlene A. Forastiere

    Pubblicazione 2004
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of... di Harry Quon, Traci Leong, Robert E. Haselow, Bruce Leipzig, Jay S. Cooper, Arlene A. Forastiere

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck di Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita Axelrod, Ronald C. DeConti, Arlene A. Forastiere

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region di Tsung‐Teh Wu, Toshiaki Watanabe, Richard F. Heitmiller, Marianna Zahurak, Arlene A. Forastiere, Stanley R. Hamilton

    Pubblicazione 1998
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma

    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma di Mark B. Orringer, Arlene A. Forastiere, Claudia Perez-Tamayo, Susan G. Urba, Bonnie J. Takasugi, Judith Bromberg

    Pubblicazione 1990
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  11. 11
    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials di Athanassios Argiris, S. Li, Musie Ghebremichael, Ann Marie Egloff, Ling Wang, Arlene A. Forastiere, Barbara Burtness, Ranee Mehra

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis di Mitchell Machtay, Jennifer Moughan, A. Trotti, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial di Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju-Whei Lee, Kamakshi Sachidanandam, Jill Kolesar, Barbara Burtness, Arlene A. Forastiere

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy di Antonio Jimeno, P. Kulesza, Jenna Wheelhouse, Andrew M. Chan, X Zhang, E Kincaid, Allen Chen, Douglas P. Clark, Arlene A. Forastiere, Manuel Hidalgo

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients di Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak

    Pubblicazione 2000
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck

    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck di Joseph Brennan, Jay O. Boyle, Wayne M. Koch, Steven N. Goodman, Ralph H. Hruban, Yolanda Eby, Marion Couch, Arlene A. Forastiere, David Sidransky

    Pubblicazione 1995
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)

    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-... di Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber, K. Kian Ang

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399

    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology... di Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Barbara A. Murphy, Michael W. Cannon, Harlan Pinto, David I. Rosenthal, Maura L. Gillison, Arlene A. Forastiere

    Pubblicazione 2007
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis

    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis di Mitchell Machtay, Jennifer Moughan, Andrew Farach, Elizabeth Martin-O'Meara, James M. Galvin, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14

    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 di K. Kian Ang, Jonathan Harris, Adam S. Garden, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber

    Pubblicazione 2005
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: